With the increasing number of drug sales, higher investments in R&D, and incorporation of new technology, the pharma industry has grown exponentially and is expected to thrive in the foreseeable future.
Given this backdrop, fundamentally strong pharma stocks Pacira BioSciences, Inc. (PCRX), Amneal Pharmaceuticals, Inc. (AMRX), and Novartis AG (NVS) could be solid buys now.
